Učitavanje...
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer
PURPOSE: To prospectively compare HRQoL effects of two modern adjuvant chemotherapy breast cancer treatment regimens at six time-points up to 16 months after random assignment. METHODS: The open-label, randomized, Phase 3 “Panther trial” was conducted between February 2007 and September 2011. 760 wo...
Spremljeno u:
| Izdano u: | Breast Cancer Res Treat |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7182635/ https://ncbi.nlm.nih.gov/pubmed/32232698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05602-9 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|